Uncategorized


Why failure is essential to progress

Science and perfection

It is easy to blame scientists for not getting things right the first time. Debates about COVID pandemic decisions often focus on what went wrong: masking, the virus’s origins, vaccination and mRNA vaccines, distancing, and transmission. Blame is easier after years of data. But this reflects a misunderstanding of science. We expect answers to be correct from the start, when science learns as it evolves. What seems possible one year can prove wrong the next. The earth is flat. The sun goes around the earth. Flies arise from spontaneous generation. All wrong. More recently, we assumed gene expression depended directly on DNA changes; epigenetics showed that life experiences can change gene activity without altering DNA.

Science knows it may be wrong and accepts that possibility. That is the basis for continued inquiry. Science is rarely satisfied with what we know; it seeks more knowledge and accepts that yesterday’s conclusions may be incomplete. That is why we can trust it. Science does not claim absolutes. It keeps working toward the closest possible version of the truth.

Yet society wants absolutes. We want “the” answer. People have asked me for the “trick” to coaching or the “recipe” for perfect decision-making. We do not accept failures or mistakes. One VP of Sales once told me, “We absolutely welcome and accept failures,” then added, “but people better not make another one.” Find me someone who has never made a mistake—or even someone who has not made one in the past week. The most dangerous mistakes are the ones left unacknowledged, unreviewed, and unused for growth. That is what I respect about science: it not only admits mistakes, it seeks them, always trying to get closer to right.

The way society treats scientific evolution—and attacks decisions made with the information available at the time—is counterproductive. We expect perfection from the very people devoted to finding better answers. To borrow from Adam Grant’s Think Again, we often accept preaching (“I tell you I am right”), prosecuting (“I tell you, you are wrong”), and politicizing (“I tell you what you want to hear”) when the scientific approach must always be: “This is what I think today based on what we know, but I am open to better ideas and will keep looking for better answers.”

In the end, science is not weakened by revision; it is strengthened by it. Progress depends on humility, curiosity, and the courage to say, “We know more now than we did before.” When we prosecute people for decisions made with yesterday’s knowledge, we discourage the very risk-taking and course correction that help humanity move forward.

The business case for imperfection

In my last post on the reality of scientific progress, I concluded that science is not weakened by revision; it is strengthened by it. Progress depends on humility, curiosity, and the courage to say, “We know more now than we did before.”

Put simply, science can be right one day and wrong the next. We must accept that if we want to move forward. Failure is not the opposite of progress; it is often the path toward it. As Thomas Edison famously said after countless attempts to invent the light bulb: “I have not failed. I’ve just found 10,000 ways that won’t work.”

I spent 12 years in pharma and another 25 consulting on talent development. In my experience, most businesses tolerate the idea of failure far better than failure itself. They may acknowledge that mistakes are part of life, but missed sales targets, implementation errors, disappointing clinical results, or unmet expectations are often treated as unacceptable. Eventually, someone is expected to pay for the mistake.  And to make this acceptable, even necessary, many business leaders will invoke that in the wild, mistakes can be fatal.  But nature does not punish to make a point, protect egos or blame others for its own benefit.  Consequences exist but they are not political or serve ill-advised purpose. 

The result is a corporate culture that quietly encourages people to hide errors, assign blame, avoid risk, preserve the status quo, and, eventually, drift toward obsolescence. Nokia, BlackBerry, Kodak, and countless others remind us of what happens when invention, creativity, and courage are pushed aside.  Failures and mistakes do happen and must serve progress for all.

In another publication (https://aseret-uido.com/accountability-as-part-of-a-mindset-leading-to-real-success/), I argue that accountability depends directly on psychological safety. We need accountability. Organizations need people willing to do what is necessary – ethically and legally – for a team, group, or company to advance and thrive. But when failure is unacceptable, people cannot be truly accountable without putting their safety, livelihood, relationships, and sense of self at risk.

Progress in business happens when we take chances, collaborate across boundaries, and candidly examine what worked and what did not. To win, we must be willing to lose, because losing is often what gives us the courage to try something different. Bell Labs developed the first silicon solar cell in 1954, yet the United States now trails far behind China in solar panel technology and production. Penicillin took nearly 20 years to move from Fleming’s discovery to mass production, where it saved thousands of soldiers’ lives in World War II. Instant gratification is a mirage we must move beyond if we want our industries – and our people – to thrive, discover, and innovate.

Organizations that punish every stumble teach people to stand still. Those that learn from failure give their people permission to be honest, accountable, and brave enough to build what does not yet exist.

The political cost of certainty

In earlier posts, I argued that science can be right one day and wrong the next. That is not weakness; it is progress. Science understands this and accepts it. The scientific method is built on the willingness to question what we believe, test better explanations, and accept that new discoveries may overturn old theories. The same acceptance of error and failure must exist in business and invention. Companies must be willing to fail, learn, and advance because of those failures. The third prong is politics.

In the United States, politics is largely shaped by two competing instincts. One side leans progressive; the other leans conservative. Policies are often designed either to control business practices or to free markets from constraint. One side tends to protect workers; the other tends to protect corporations. One believes government must oversee and regulate; the other believes government has grown too large and should get out of the way. Both perspectives can be right, and both can be wrong. Too much regulation can slow progress and create enormous costs. Too little intervention can discourage investment in science and long-term innovation because it favors only what produces immediate returns.

More damaging is the inability of either side to admit mistakes. Because political leaders must satisfy their base, remain visibly conservative or clearly progressive, and win the next election, politics rarely rewards collaboration. Helping the other side look reasonable is treated as weakness. This is the opposite of the scientific approach, where failure is not an embarrassment to hide but evidence to examine.  The most effective and viable businesses favor collaboration, teamwork and constant innovation.

Why address politics at all? Because politics shapes whether a society encourages risk, curiosity, and long-term investment – or punishes them. Over the last few decades, the United States has often originated powerful ideas but failed to develop, scale, or sustain them as effectively as others. We point to the iPhone and Tesla, but the iPhone is manufactured largely in China, and Tesla depends heavily on battery supply chains rooted in Asia. Internet infrastructure, high-speed rail, mobile payments, electric vehicles, public transit, smartphones, and many other life-changing innovations were either invented or pioneered in the United States, then developed more aggressively elsewhere. In many cases, politics is part of the reason. We either overprotect ourselves from abuse in ways that burden honest innovators, or we invest only in what creates quick wealth, with too little patience for long-term discovery. We have become risk averse. We struggle to admit mistakes. We narrow our horizons. And the price we pay may be enormous, even if it is hard to measure.

Progress requires more than brilliant scientists and courageous businesses; it requires a political culture humble enough to learn. When politics cannot admit error, it does not protect the future. It protects the past.

The boring work that builds the future

I discovered a fascinating book by happy accident. Abundance, by Ezra Klein and Derek Thompson, is a powerful reminder of how much better life has become, and why. It traces the hard-won lessons behind progress, points to practical solutions, and confronts some of the ways science has gone – and is still going – wrong. I want to use it as another reason to address a key aspect of our lives, one that is too often overlooked: taking risks, accepting mistakes, and learning from both. Fundamental research is the area I would like to visit today. To many people, it looks boring, wasteful, or detached from real life – the domain of eccentrics, outsiders, and antisocial weirdos. Yet, as Patricia Pitcher argues in Artists, Craftsmen, and Technocrats, we tend to prize results, outcomes, measurements, and immediate usefulness above the deeper work that makes those outcomes possible.

Take the iPhone. We often elevate Steve Jobs as the lone genius behind it. That takes nothing away from his brilliance, but he could not have created the iPhone without decades of essential contributions from people pursuing ideas that once seemed impractical, obscure, or even absurd.

The transistor was invented in 1947. Lithium-ion batteries emerged from research in the 1970s. Cellular networks began taking shape in the late 1970s. Touchscreens were first imagined in the 1960s, and GPS technology traces back to the 1970s. These are only a few of the scientific advances required to create the device we now treat as obvious.

The same is true in medicine. How many people are now treating diabetes or losing weight because of GLP-1 drugs? That story began with a researcher studying the saliva of a venomous lizard because of its ability to fast for months. At the time, it may have looked like an odd curiosity. Today, it is changing lives.

As a society, we too often forget the obscure individuals behind the progress we enjoy. We mock their questions, dismiss their obsessions, and undervalue their contributions—until their work becomes part of everyday life. Then we call it normal.

We easily overlook the efforts invested in figuring out how Nature does what it does.  It is true that countless investigations into obscure realities have failed to produce immediately applicable knowledge.  At times, the “failed” findings lead to nothing.  In other cases, they become relevant years after their discovery as a “dead end”.  Boolean algebra is a good example.  A logical system using the very simple “true” and “false” in mathematics.  It took 100 years for the concept to become relevant and generate the invention of digital computers and microchips. 

Fundamental research faces more skepticism than almost any other human endeavor. Failed attempts to explain natural phenomena are common. But if we measure its value only by immediate results, or only by whether the findings confirm the original premise, we put progress at risk. When we treat failed experiments, wrong turns, or unexpected results as wasted effort, we are not saving resources; we are divesting from the future. Science has failed often, but because scientists kept asking questions, testing assumptions, and learning from those failures, we now enjoy a quality of life unimaginable just 100 years ago. That willingness to adjust is the scientific mindset: accepting that what seems true today may not be tomorrow.

Perhaps that is the quiet genius of fundamental science: it asks questions long before the world understands why they matter. It gives us no guarantee, no quick reward, and often no applause. But somewhere in that uncertainty, someone is building the future we will one day take for granted.

Not every failure deserves applause.

That distinction raises the question readers often ask next: if failure can drive progress, does that mean all failures deserve patience, forgiveness, or praise? The answer is no. The value of failure depends on why it happened, what risk was visible beforehand, and whether anyone had the courage to learn from it.

When I argue that we must accept and learn from errors or failures, I am not defending reckless judgment, misguided intent, or careless action. A good failure begins with a responsible attempt to improve something: a process, a principle, a product, a treatment, or any effort meant to support clients, strengthen a company, or help a team succeed ethically. It remains a good failure only if we learn from it and use that learning to improve. New treatment options tested on the basis of early research fail often. We rarely see those failures, but they are part of how better solutions eventually emerge.

Corporations avoid failure because it costs money, reduces profitability, threatens reputation, and can damage perceptions of quality. But avoiding every possible failure can create far worse outcomes. It can hinder progress, stall discovery, and intensify the very risks leaders hope to avoid. Mistakes are not the main issue. The real problem is making mistakes for the wrong reasons, then refusing to learn from them. Nokia, BlackBerry, Kodak, Sears, and Blockbuster are examples of companies that stopped challenging themselves and tried too hard to avoid failure. In the end, that avoidance became its own kind of failure.

Failures that come from poor planning, impulsive action, or the conscious dismissal of available evidence are bad failures. The Challenger space shuttle disaster in 1986 is a painful example of a predictable failure. Groupthink, siloed decision-making, image management, dismissal of evidence, and other warning signs all contributed to a disaster that could have been avoided. Launching despite available knowledge about the O-rings led to the loss of lives and damaged NASA’s reputation and public support. The tragedy did focus attention on the O-ring issue, but that lesson did not require catastrophe. That is a bad failure.

Chernobyl is another example of a failure that should have been avoided. So was the Titanic. In both cases, warning signs existed, and people in positions of responsibility failed to act on them. Hubris, complacency, and deference to power are often the foundations of awful decisions and avoidable disasters.

Many failures do produce results that are much more positive than negative.  The discovery of penicillin was caused by a lack of attention to possible contamination which was not very clear in those days and could hardly be predicted.  Coca-Cola was originally created as a medicinal product.  The Berlin Wall came down when it did because incorrect information was given to the population.  A mistake that accelerated the movement of liberation and changed people’s lives for the better very quickly.

By definition, a bad failure is one that has evident negative outcomes putting people’s livelihood at risk, and which outcomes are dismissed or consciously overlooked.  Another variation is a failure based on illegal, unethical or intentionally harmful intent.  A “good” failure comes from the intent to help, contribute to growth or add value.  Edison’s intent was to develop a device that would change people’s lives for the better.

Failing is not the problem. The value of failure depends on why it happens, what risk was visible beforehand, and whether anyone has the courage to learn from it.

Progress can be messy.  Moving humanity forward implies mistakes and failure at the beginning.  As we learn from failure, we move in the right direction, or at least in a “better” direction.  As much as we must celebrate success, we must also celebrate failure.  We do not do this blindly or excuse negligence, we accept failure for the opportunities it opens.

If we want better science, stronger organizations, wiser politics, and more durable innovation, we must build cultures that can admit error without collapsing into blame.   Rewarding curiosity leads to new learning which in turn helps us adapt to various situations.  Accepting mistakes encourages accountability which promotes our determination to continuously improve and aim for some form of excellence.  Our future depends on our courage to fall and determination to get back on our feet to evolve.


Key Account Managers (KAMs) and Medical Science Liaisons (MSLs): The present and future of Pharma. 1

First, let’s look at WHY we think Key Account Managers (KAM) and Medical Science Liaisons (MSL) are critical to the success in Pharma (Healthcare industry)? 

Both these functions have been around for many years in Pharma.  That’s not news.  Like many other roles, the two have significantly evolved, and now need to be an even more significant part of the key strategies for development.  There are a number of reasons for this.  But before we get there, it is important to recognize that Pharma is a business and as such, strategies should always aim to optimal profitability while prioritizing the benefits to patients.  After all, patient centricity has been at the heart of Pharma’s efforts for many years.

KAMs, depending on their scope from one company to the other, are able to conduct the orchestra of stakeholders for the benefit of HCPs.  There are many versions of KAMs.  In this short article (and the following), we define KAMs as individuals that are responsible to identify customer’s needs in a wide variety of areas, help  develop solutions to meet those needs, and orchestrate the work of a number of stakeholders for the solutions to materialize.   The projects KAM manage or help create are often innovative, unique or essential to the advancement of the whole business model.  Very often, initiatives are not directly targeting prescription, or advocacy, or immediately measurable returns for all stakeholders.  Rather, they bring perspective, options and actions that foster an environment for better care, or effort allocation.  As an example, KAMs have led initiatives to better standardize the evaluation of people suffering from depression, increase the precision of the diagnosis and better orient treatment choices.  The initiative was created in concert with HCPs and eventually, led by the HCPs.  KAMs simply facilitated the discussions and brought resources together.  They are project managers and, hopefully, concentrate their actions where both industry and HCPs gain, for the ultimate benefit of patients.  We will explain WHY they are critical.

MSLs are scientific and clinical experts.  They are often physicians, nurses, pharmacists and PhDs.  Because of their formal training and role, they are able to discuss clinical aspects that commercial teams cannot, or will not.  MSLs also have the specific role to review the mountain of data in given clinical areas.  In oncology for example, some of the MSLs I know are so globally knowledgeable that HCPs count them as a part of their team, their brain power.  While it may be argued that MSLs may not always be neutral in their perspective, after all they do work for Pharma or Medical Devices companies, their training, and often their oaths to their profession (MDs, PharmDs, PhDs, etc.) more often than not counter the possibility to stray to unreasonable levels of partiality.  Not reporting to commercial groups and not receiving commercial incentives also help.  Yet, MSLs are able to guide HCPs in directions that better serve patients. 

So WHY are those two function so critical?

Both KAMs and MSLs have the ability and respectability to influence HCPs in optimal directions.  As I look back at the Principles for Persuasion by Cialdini, KAMs and MSLs can more easily (than others) leverage each of the principles.  Because of their superior knowledge they have Authority.  Their ability to relate and remain balanced in their approach makes then Likeable and inspire Reciprocity.  The capacity for KAMs and MSLs to be Consistent and bring fair perspective help their influence on Social Proof (people follow the lead of similar others).  Finally, when they are highly competent, and because there are far less of them at that level, they appeal to Scarcity (people want more of what they can have less of).  

KAMs and MSLs are able to generate more value for HCPs.  Commercial teams also have that ability, but they are significantly limited because of numerous factors.  KAMs can create solutions that go far beyond the treatment of single individuals and the “traditional” process.  The example I gave earlier with depression illustrates this.  KAMs can work on projects that help large clinics or treatment groups be more effective.  In the case of diabetes, projects have gathered a number of specialties to truly optimize the treatment approach and disease management.  This has produced significant cost savings for all stakeholders.  Helping HCPs make better choices will likely contribute to the profitability of project sponsors.   But this will not come via a distorted view of treatment options.  It will hopefully be generated by a rational approach, ensuring that the best option is selected for the right patient.  Think of the current opioid crisis.  Most of those drugs are necessary for patients that need pain management.  It can be argued that a part of the crisis is the result of incomplete understanding of pain management, and possibly an approach that did not involve a sufficient number of specialties.  While some companies have greatly benefited financially, the end result is extremely detrimental to reputations, credibility, HCPs that aim to do the right thing, patients and society in general.  KAMs can contribute to projects for which profitability will likely be established on actual best practices and ensure the viability of efforts.  As products are used more rationally, the results will improve for all stakeholders.   Increase in fairness, better results and fewer negative impacts will likely generate more synergy between stakeholders as opposed to acrimony and suspicion.  That is in part, WHY KAMs are a critical part of the future.

MSLs are able to put in perspective the mountain of data available.  They can speak to the present as well as the future.  Their interactions with leaders in their fields (clinicians, scientists, developers), and the fact that understanding data and trends is their main role, makes them moderators.  As such, they are able to calm down certain undue cravings for unruly usage of the new and improved.  MSLs have foreseen the opioid crisis.  MSLs are therefore better equipped to highlight dangerous paths and promote a balanced usage of all the worthy solutions.  Because of their credibility and balanced approach, MSLs have the ability to address situations in a manner that will bring a more universally advantageous approach to treating patients.  Just like KAMs, in their own way, MSLs can produce an increase in fairness, better results and fewer negative impacts to generate more synergy between stakeholders as opposed to acrimony and suspicion.  That is in part, WHY MSLs are a critical part of the future.

I mentioned Cialdini earlier.  Let me link his principles of persuasion to the intrinsic value of KAMs and MSLs in Pharma.  At the moment, some of the most acute problems faced by Pharma and Medical Devices companies are access to their customers, credibility, the perception of value (other than a treatment of quality), the impression that they don’t truly contribute to the overall healthcare environment (product focus instead of health focus), and the conviction that all that counts is industry progress as opposed to the development of the complete environment.  While it is not universal or unanimous, HCPs may see the industry as a taker rather than a contributor.  That’s where KAMs and MSLs contribute to change that reality.

Access.  While it has been advocated for years now that sales representatives need to “up their game” and bring more global knowledge and skills to their customers, regulations can significantly limit their ability to use such capabilities.  However one feels about the changes implemented in Pharma’s commercial practices, there have been both positive and negative impacts associated to new rules of engagement.  When we amalgamate those limitations to a persistently volatile perception of their value, the potential positive impact that teams can have, often remains torpedoed compared to their true capabilities.  This directly impacts access.

When time is precious, we tend to choose with more discernment where we invest it.  In most cases, HCPs will choose to invest where there is a potential return.  This is WHY KAMs and MSLs have more attraction and increased access.

Credibility.  Not directly promoting any specific product, in spite of being employed by a corporation, contributes to the credibility of KAMs and MSLs.  With the incredible amount of information available to HCPs, it is particularly critical to decipher the wheat from the chaff.  KAMs and MSLs both have that capability, which turns into an advantage.  Credibility breeds confidence which in turn, promotes loyalty.  Loyal customers are critical to profitability.  This explains WHY KAMs and MSLs need to be more strategically integrated.

Value. KAMs and MSLs bring ideas and perspectives contributing to the evolution of HCPs.  As such, they help enhance the reputation, productivity, precision of treatment, time management and resource allocation of HCPs.  It is rather easy to translate any of this into added value.  When someone has value to us, we tend to treat them well, and we care for their perspective.

Contribution.  As mentioned earlier, KAMs and MSLs are often able to become partners or consultants for HCPs. Projects such as the one I briefly mentioned with depression, help HCPs enhance their ability to perform at a higher level.   KAMs and MSLs that are able to contribute to HCPs’ scope gain significant impact.  Another reason WHY they are critical.

Progress.  Let’s face it, with the amount of new data generated these days, it is almost impossible as an individual or a specialized group to fully integrate what is available.  Humans are notorious for finding a level of comfort in their daily activities and cruise.  KAMs and MSLs will help HCPs shake their habits, inspire them to dare new avenues.  The generated progress will benefit the therapeutic areas and patients.  Who doesn’t want to be a part of that?

 Hopefully, this has provided an illustration for WHY KAMs and MSLs are so critical for the future of Healthcare efforts.  The next article in this series will address HOW to best integrate and develop KAMs and MSLs in the industry.

But wait.  As much as this text supports the continued development of KAMs and MSLs, bestowing upon them a strategic importance, it should also be an indicator for the orientation of commercial teams in the Healthcare industry.  Commercial teams can still play a strategic role and remain of critical value.  Knowledgeable individuals that are not solely dominated by their personal performance or metrics, that care about a balanced approach supported by evidence, and working to look at possibilities and valid options are arguably the most profitable sales people imaginable.

For a few immediate ideas on the HOW, please visit http://aseret-uido.com/programs/


Hiring based on Values rather than Skills

How much of the time allocated for job interviews is spent on trainable skills rather than unchanging values and traits?  It is completely reasonable to hire people on account of their immediate ability to perform tasks.  Employers often open a job because the need is immediate.  As such, teams are looking to find a person that will be able to perform very quickly.  There is nothing wrong with that.  What becomes problematic is to put too much value on skills, and too little on values, traits and synergy.

Imagine someone joins your team because they have ALL the skills you are looking for but clearly disrupts the team dynamics because of their attitude and mismatch in core principles.  How do we evaluate the added value of skills against the tensions and disruptions in the team?  Let’s say the new person is hired because of their strong ability to include social media initiatives in the company’s efforts.  The positive may be that the corporation will be able to post news, innovations, events and other important information, frequently and with effectiveness.  In turn this will likely create new business, or consolidate the corporate image to retain existing business.  Now, while the new person is able to perform their task, this individual also makes many others on the team very uncomfortable.  Let’s assume that the discomfort comes from the rudeness, and lack of respect and understanding of the new person.  In addition, the new employee has no interest in understanding the realities of the people responsible for creating the news, innovations, events and other important information to be added to the social media initiative.  As a result, what ends up being published may be of lesser quality.  Why?  Some of the reasons may be linked to pressure to meet new deadlines, lack of clarity on the format necessary for best social media impact, reduced motivation to help a colleague that treats us with disrespect, stress, and a multiple of other aspects.  Why is that the problem of the new person?  It isn’t.  If the team in place has always been competent in their roles, the problem resides in the person that hired the new person.  If the current team was not effective for some reason, the problem lies with the leader of that team for not managing the problem, and hiring the new person at the time they did.

Now imagine that the new person is not as skilled as the other we just described but is determined to mesh with the existing team, learn from them,  about their respective roles, and explain what needs to be done for the social media initiatives to work.  The new person’s ability may, in the short term, be less impressive than the other person but still, their abilities are very decent, and the information that is transmitted is of higher quality.  Which of the two situations seems most productive?  Looking at both examples of new people, which one is most likely to learn from others and increase their social media competencies in the next 6 months.  Furthermore, depending on the stress and disruption of hiring the fist new person, what will be the costs associated to one or two or more people from the existing team leaving?

I have been in rooms full of new hires to provide development of various skills.  I have experienced the disruption of individuals thinking that they were above such efforts because their perception was that they were stars, hired specifically for their existing skills rather that their determination to work as a team, or to learn new approaches.  I have witnessed the decrease in productivity of the whole team because of mismatched values, traits and synergy.  And, I have been privy to teams loosing up to 50% of its members within a year or two of “prima donnas” being hired.  In the vast majority of cases, the corporation (and its clients) lost much more than they gained.

Competencies can be learned and developed.  Values and traits are deep seated and seldom change.  A corporation needs to hire accordingly.


The evolution of dynamic communication

In line with the trends identified in the last 12 years, Dynamic and Engaging Communication continues to rank as one of the highest needs in Talent Development.

What is Dynamic and Engaging Communication and why is it important?

 

An effective communicator is an astute influencer in all areas of Leadership, including Presentation/Facilitation, Decision Making, Hiring, Change Management, Executive Coaching, Key Account Management, Stakeholder Management, and one of most impactful skills, Effective Listening.

Our customers come to us with both urgent and increasing need for Engaging Communication Skills.

 

Over the last few years, we led over 20 programs involving Medical Education Professionals, Medical Science Liaison Specialists and a large number of Physicians, Advance Practice Nurses and Pharmacists in 10 Biopharmaceutical Therapeutic Areas.

We propagated best practices in Case Study facilitation, Remote Meeting Management, Clinical Discussion Facilitation, Educational Facilitation as well in Dynamic Presentations Skills.  In all of these courses we heard loudly from our customers, this is EXACTLY what they needed in order to clearly deliver impactful, dynamic, scientific presentations which keep the audience fully engaged, throughout the presentations and well into the Q and A Sessions, along with feedback from participants on the need for more information.

 

For the last 15 years, Leadership Development has been our most active sector.  While coaching and development of teams have been the main areas of interest, hiring skills specifically dynamic interviewing methods – are gaining interest. So much so, that we are in the process of writing an e-book.  We also developed a half day workshop on the topic, in an effort to adapt to growing requests.

Due to the numerous transformations in Healthcare Commercialization, Change Management and Key Account Management have regained momentum in our curriculum.  Decision Making/Risk Taking, which was usually reserved for C-Suite executives, is now being offered by many organizations to their employees in order to empower them with skills to better think outside the box and to adapt to the constant change in business realities.

Executive Coaching works in concert with Leadership Development activities.  Our sector specializing in the development of competency models and career paths.  Clarity of roles and expectations, along with the proper support by leadership teams, generate increased dynamism in the workforce.

New kids on the block are programs on resource allocation (QQTR) and managing challenging situations.

The question organizations need to contemplate is this, “are we part of the innovative and dynamic leaders that are creating the new present, or are we deciding to follow later, and play catch up?”  If you are in the first group, we want to collaborate and help you make that difference.


Gratitude

Fifteen years seem a long time and yet, the whirlwind of projects, innovations and progress happens in what seems like seconds.  A business is a wonderful vehicle to make a difference in many people’s lives.  It impacts the individuals that work in the corporation as well as those who contribute as partners and suppliers.  In more than one way, an enterprise such as Aseret and many others like us, contribute to the development of talent and consequently the profitability of clients.  Yet we often forget to recognize the difference every single one of the people and groups mentioned previously have made for us.  I am referring to the perspective we gained through our efforts to clearly understand customers’ business realities.  The impact is also felt via challenges offered to us, confrontation of ideas and discussions on strategies to optimize our services.  Over the years, individuals and teams that trusted our intent have supplied the platform for new product development.  As a result of this, we evolved from one niche product to over 17 different programs, each existing in various iterations to meet the needs of different stakeholders.  Aseret is now active in 3 spheres of Talent development, each intimately connected and yet often worlds apart considering the depth of collaboration they carry.  After 15 years in business we need to recognize the incredible synergy we have had the chance to develop and the priceless contribution clients have imparted on the difference we strive to make in our daily efforts.  To all our past, current and future partners, we offer our most sincere gratitude.